Description
Livagen Peptide Product Description
Livagen peptide is a synthetic tetrapeptide bioregulator composed of the amino acid sequence Lys-Glu-Asp-Ala (KEDA). Originally developed as part of Khavinson peptide research, Livagen has attracted scientific interest for its potential role in epigenetic regulation, immune system function, liver health, chromatin remodeling, and cellular aging. Laboratory investigations suggest that Livagen may interact directly with DNA and chromatin structures, potentially influencing gene expression associated with immune activity and tissue function.
Unlike receptor-dependent peptides, Livagen has been investigated for its ability to influence chromatin organization within the cell nucleus. Researchers propose that the peptide may promote chromatin decondensation, potentially restoring access to genes that become less active during the aging process. This unique mechanism has made Livagen a valuable research compound in studies involving immunology, hepatology, molecular biology, and healthy aging.
Our research-grade Livagen peptide is manufactured to high purity standards and supplied as a lyophilized powder for laboratory research applications.
Potential Research Benefits of Livagen Peptide
Current laboratory research suggests Livagen may support investigations involving:
- Chromatin remodeling and epigenetic gene regulation
- Immune system and lymphocyte function
- Liver cell protection and hepatic regeneration
- Healthy cellular aging mechanisms
- DNA interaction and transcription regulation
- Antioxidant defense pathways
- Gastrointestinal tissue function
- Cytokine and inflammatory signaling
- Enzymatic activity related to endogenous opioid peptides
- Cellular stress response and tissue homeostasis
Potential Research Effects
Experimental studies suggest Livagen may:
- Influence chromatin organization within immune cells
- Promote expression of genes involved in protein synthesis
- Support lymphocyte activation and immune regulation
- Enhance antioxidant enzyme activity during liver research
- Influence digestive enzyme function in gastrointestinal studies
- Modulate inflammatory signaling pathways
- Support genomic stability during cellular aging research
- Protect thymic structure in immune function investigations
- Influence endogenous enkephalin metabolism
- Support cellular resilience under oxidative stress
Additional research is ongoing to better understand Livagen’s biological activity and molecular mechanisms.
Livagen Peptide Dosage (Research Protocol)
Research Use Only
Published laboratory protocols commonly investigate Livagen using:
- Dose: 10 mg
- Frequency: Once daily
- Cycle Length: 10 days
- Route: Determined by individual laboratory research protocol
Dosage protocols reported in scientific literature are intended solely for controlled laboratory investigations and are not established for human or veterinary use.
Product Specifications
Peptide Name: Livagen
Sequence: Lys-Glu-Asp-Ala (KEDA)
Molecular Formula: C18H31N5O9
Molecular Weight: 461.5 g/mol
CAS Number: 195875-84-4
Appearance: Lyophilized White Powder
Purity: Research Grade
Storage: Store refrigerated before reconstitution. Long-term storage is recommended at -20°C.
Research Use Only – Not for Human Consumption.
